Peptide record

TPDB91717

Temporin-PE Antibacterial Anticancer Antifungal Antiviral Hemolysis Toxicity modified_plain modified
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91717
Temporin-PE
Antibacterial Anticancer Antifungal Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 dbACP iACP-DRLF Antifungipept CAFPdb dbAMP 3.0 APD_complete PD_Hemolysis ToxinPred 3.0
modified_plain
Yes
A 13-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
FLPIVAKLLSGLL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
13 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial and Anticancer Activity
Pelophylax kl. esculentus Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
IC50 = 34.56 µM
Anticancer
34.56 µM

Target

Lung Cancer
NCI-H-157
Lung

Assay & Model

MTT assay
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2018

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 2 Activity

Activity

IC50
IC50 = 25.13 µM
Anticancer
25.13 µM

Target

Brain Tumor
U251-MG
Brain

Assay & Model

MTT assay
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2018
Evidence 3 Activity

Activity

IC50
IC50 = 38.56 µM
Anticancer
38.56 µM

Target

Prostate Cancer
PC-3
Prostate

Assay & Model

MTT assay
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2018
Evidence 4 Activity

Activity

IC50
IC50 = 33.23 µM
Anticancer
33.23 µM

Target

Skin Cancer
MDA-MB-435S
Skin

Assay & Model

MTT assay
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP
CancerPPD2
2018